Cargando…
Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
AIM: While evidence‐based antidepressant treatment is available for major depressive disorder, standard approaches for discontinuation of antidepressants after remission have not yet been established. Decision aids are structured clinical tools that facilitate shared decision‐making between patients...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515698/ https://www.ncbi.nlm.nih.gov/pubmed/35775506 http://dx.doi.org/10.1002/npr2.12269 |
_version_ | 1784798543264874496 |
---|---|
author | Aoki, Yumi Takaesu, Yoshikazu Baba, Hajime Iga, Jun‐ichi Hori, Hikaru Inoue, Takeshi Mishima, Kazuo Tajika, Aran Kato, Masaki |
author_facet | Aoki, Yumi Takaesu, Yoshikazu Baba, Hajime Iga, Jun‐ichi Hori, Hikaru Inoue, Takeshi Mishima, Kazuo Tajika, Aran Kato, Masaki |
author_sort | Aoki, Yumi |
collection | PubMed |
description | AIM: While evidence‐based antidepressant treatment is available for major depressive disorder, standard approaches for discontinuation of antidepressants after remission have not yet been established. Decision aids are structured clinical tools that facilitate shared decision‐making between patients and healthcare providers. This study aimed to describe the development process and acceptability of decision aids for major depressive disorder following discontinuation of antidepressant treatment after remission. METHODS: We systematically developed a decision aids according to the International Patient Decision Aid Standards. First, a decision aids prototype was created using the results of a systematic review and meta‐analysis previously conducted to identify the consequences of continuing and discontinuing antidepressant treatment. Second, a mixed‐methods questionnaire (alpha acceptability testing) was administered to patients and healthcare providers to improve the decision aids prototype and develop it into a final version acceptable for clinical settings. RESULTS: Our decision aids consisted of a description of major depressive disorder, the option to continue or discontinue antidepressant treatment, the advantages and disadvantages of each option, the consequences of each option, and value clarification exercises for each option. The patients (n = 22) reported that the decision aids had acceptable language (91%), adequate information (91%), and a well‐balanced presentation (95%). Healthcare providers (n = 20) provided favorable feedback. The final decision aids fulfilled all six International Patient Decision Aid Standards qualifying criteria. CONCLUSION: We successfully developed a decision aids for discontinuation of antidepressant treatment after remission, which could be used during the shared decision‐making process. Further studies are needed to verify the effects of using the decision aids during the shared decision‐making process. |
format | Online Article Text |
id | pubmed-9515698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95156982022-10-05 Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission Aoki, Yumi Takaesu, Yoshikazu Baba, Hajime Iga, Jun‐ichi Hori, Hikaru Inoue, Takeshi Mishima, Kazuo Tajika, Aran Kato, Masaki Neuropsychopharmacol Rep Original Articles AIM: While evidence‐based antidepressant treatment is available for major depressive disorder, standard approaches for discontinuation of antidepressants after remission have not yet been established. Decision aids are structured clinical tools that facilitate shared decision‐making between patients and healthcare providers. This study aimed to describe the development process and acceptability of decision aids for major depressive disorder following discontinuation of antidepressant treatment after remission. METHODS: We systematically developed a decision aids according to the International Patient Decision Aid Standards. First, a decision aids prototype was created using the results of a systematic review and meta‐analysis previously conducted to identify the consequences of continuing and discontinuing antidepressant treatment. Second, a mixed‐methods questionnaire (alpha acceptability testing) was administered to patients and healthcare providers to improve the decision aids prototype and develop it into a final version acceptable for clinical settings. RESULTS: Our decision aids consisted of a description of major depressive disorder, the option to continue or discontinue antidepressant treatment, the advantages and disadvantages of each option, the consequences of each option, and value clarification exercises for each option. The patients (n = 22) reported that the decision aids had acceptable language (91%), adequate information (91%), and a well‐balanced presentation (95%). Healthcare providers (n = 20) provided favorable feedback. The final decision aids fulfilled all six International Patient Decision Aid Standards qualifying criteria. CONCLUSION: We successfully developed a decision aids for discontinuation of antidepressant treatment after remission, which could be used during the shared decision‐making process. Further studies are needed to verify the effects of using the decision aids during the shared decision‐making process. John Wiley and Sons Inc. 2022-07-01 /pmc/articles/PMC9515698/ /pubmed/35775506 http://dx.doi.org/10.1002/npr2.12269 Text en © 2022 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Aoki, Yumi Takaesu, Yoshikazu Baba, Hajime Iga, Jun‐ichi Hori, Hikaru Inoue, Takeshi Mishima, Kazuo Tajika, Aran Kato, Masaki Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
title | Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
title_full | Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
title_fullStr | Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
title_full_unstemmed | Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
title_short | Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
title_sort | development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515698/ https://www.ncbi.nlm.nih.gov/pubmed/35775506 http://dx.doi.org/10.1002/npr2.12269 |
work_keys_str_mv | AT aokiyumi developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT takaesuyoshikazu developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT babahajime developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT igajunichi developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT horihikaru developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT inouetakeshi developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT mishimakazuo developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT tajikaaran developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission AT katomasaki developmentandacceptabilityofadecisionaidformajordepressivedisorderconsideringdiscontinuationofantidepressanttreatmentafterremission |